Objective: The effects of mitotane on the pharmacokinetics (PK) of co-administered drugs are mostly
unknown. The aim of the present study was to describe the effects of mitotane on the PK of the
phenotypic probe midazolam and of the tyrosine kinase inhibitor sunitinib.